Anna Glaser

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (4)

Jiří Drahota

General University Hospital in Prague

CZECH REPUBLIC

View details

Peter Mol

Professor Drug Regulatory Science

University Medical Center Groningen

NETHERLANDS

View details

Rodden Middleton

Associate Professor of Disease Registers and Health Data

Swansea University

UNITED KINGDOM

View details

Ali Manouchehrinia

The University of British Columbia

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Glaser

Research Interests

Explore related searches

Contact this professor

Articles (10)

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies

Big Multiple Sclerosis Data network: an international registry research network

Socioeconomic status and quality of multiple sclerosis care in Sweden.

Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis

Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context.

The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.

Trajectories of disease-modifying therapies and associated sickness absence and disability pension among 1923 people with multiple sclerosis in Sweden.

Copy number variations across the blood-brain barrier in multiple sclerosis.

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis.

Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.

Collaborators (4)

Jiří Drahota

Peter Mol

Rodden Middleton

Ali Manouchehrinia

Make your next move.